Enzyme-Driven Switchable Fluorescence-SERS Diagnostic Nanococktail for the Multiplex Detection of Lung Cancer Biomarkers

Saranya, Giridharan ; Joseph, Manu M. ; Karunakaran, Varsha ; Nair, Jyothi B. ; Saritha, Valliamma N. ; Veena, Vamadevan S. ; Sujathan, Kunjuraman ; Ajayaghosh, Ayyappanpillai ; Maiti, Kaustabh K. (2018) Enzyme-Driven Switchable Fluorescence-SERS Diagnostic Nanococktail for the Multiplex Detection of Lung Cancer Biomarkers ACS Applied Materials & Interfaces, 10 (45). pp. 38807-38818. ISSN 1944-8244

Full text not available from this repository.

Official URL: http://doi.org/10.1021/acsami.8b15583

Related URL: http://dx.doi.org/10.1021/acsami.8b15583

Abstract

Comprehensive profiling of multiple protein targets plays a critical role in the deeper understanding of specific disease conditions associated with high heterogeneity and complexity. Herein, we present the design and fabrication of smart programmable nanoarchitectures, which could integrate clinically relevant diagnostic modalities for the multiplexed detection of most prevalent panel of disease biomarkers present in lung cancer. The multiplex nanoprobes were prepared by attaching dual-functional Raman active fluorogens onto spherical gold nanoparticles through a peptide linker, Phe-Lys-Cys (FKC) which is engineered with a cathepsin B (cathB) enzyme cleavage site. Presence of the cathB induces the scission of FKC upon homing into the cancer cells, resulting in the release of the initially latent fluorophores with a concomitant quenching of the surface enhanced Raman signal intensity, thereby realizing an on-off switching between the fluorescence and Raman modalities. The enzyme triggered switchable nanoprobes were utilized for the simultaneous detection of pathologically relevant lung cancer targets by tethering with specific antibody units. The multiplex-targeted multi-color coded detection capability of the antitags was successfully developed as a valid protein screening methodology which can address the unmet challenges in the conventional clinical scenario for the precise and early diagnosis of lung cancer.

Item Type:Article
Source:Copyright of this article belongs to American Chemical Society
ID Code:129953
Deposited On:28 Nov 2022 11:30
Last Modified:28 Nov 2022 11:30

Repository Staff Only: item control page